1. Buss LF, Prete CA, Abrahim CMM, Mendrone A, Salomon T, de Almeida-Neto C, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–92.
2. Sabino EC, Buss LF, Carvalho MPS, Prete CA, Crispim MAE, Fraiji NA, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet. 2021;397(10273):452–5.
3. Coutinho RM, Marquitti FMD, Ferreira LS, Borges ME, da Silva RLP, Canton O, et al. Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant. medRxiv. 2021. Available from: https://www.medrxiv.org/content/early/2021/03/09/2021.03.03.21252706.
4. de Souza FSH, Hojo-Souza NS, Batista BDdO, da Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PLOS ONE. 2021;16(3):1–21.
5. Naveca F, Costa C. Caracterização genética do SARS-CoV-2 circulante no Estado do Amazonas. Nota Técnica Conjunta No 09/Fiocruz/ILMD E FVS-AM; 2021. Published online Jan 28. [Accessed March 15, 2021]. Available from: https://amazonia.fiocruz.br/wp-content/uploads/2021/01/NOTA-TE%CC%81CNICA-CONJUNTA-N%C2%BA-09.2021.FVS-AM-X-ILMD.FICRUZ-AM-28.01.2021.pdf.